US Strikes Iran Nuclear Sites, New HIV Preventative Drug Approved, and Pixar's Box Office Flop

US Strikes on Iran's Nuclear Facilities

• 🎯 President Trump announced US strikes on Iranian nuclear sites, describing the mission as a success with "monumental damage" to underground facilities.
• ⚠️ Iran and Israel continue to trade strikes, with Iran reserving options for response, while the US warns of greater retaliation for any Iranian aggression.
• 🛡️ Colonel Jack Jacobs explains that while direct attacks on US troops are unlikely due to expected retaliation, Iran may use proxies, particularly targeting Israel, and cyber attacks are a significant concern.
• 🌍 The conflict's impact on oil markets and the Strait of Hormuz is discussed, with a low likelihood of disruption due to Iran's relationship with China and Russia.
• 🏛️ In Washington, Republicans largely support the strikes, but a Senate vote on requiring congressional approval for continued military force against Iran is expected.
• 🗣️ Some lawmakers, including Marjorie Taylor Greene, have expressed dissent, questioning the constitutionality and necessity of US involvement in foreign wars.

Landmark HIV Preventative Drug Approval

• ✨ Gilead Sciences CEO Daniel O'Day discusses the FDA approval of Yeztugo, a twice-yearly injectable for HIV prevention.
• 💉 This new drug offers nearly 100% protection and aims to address compliance issues associated with daily pills, potentially marking a significant step towards ending the AIDS epidemic.
• 📈 Despite its high cost ($28,000 annually), Gilead is working to ensure accessibility through insurance coverage, patient assistance programs, and licensing agreements with generic manufacturers for low and middle-income countries.
• 🌍 The drug's importance is highlighted by the ongoing HIV crisis, with disproportionately rising rates in certain US regions and significant global impact.

Pixar's 'Elio' Box Office Disappointment

• 📉 Pixar's latest film, Elio, experienced the worst opening weekend in the studio's history, grossing only $21 million in North America.
• 💰 The film, with a production and marketing cost of at least $250 million, underperformed significantly, raising questions about Pixar's strategy of relying on original intellectual property.
• 💡 Discussions arise about whether Pixar should leverage Disney's existing library of IP for future films, similar to successful strategies employed by other studios with franchises like "Barbie" and "Super Mario."